Search for a command to run...
Neogen Chemicals Ltd. has demonstrated robust revenue growth and remains competitive in profitability metrics, though its valuation suggests it may be overvalued compared to peers. The company shows potential for growth, but investors should be cautious of its high PE ratio relative to its peers.
Stock | CMP | Market Cap | P/E | ROE (%) | ROCE (%) | Debt/Equity |
|---|---|---|---|---|---|---|
| NEOGEN | ₹1,471.20 | ₹3,803.05Cr | 113.05 | 4.50% | 7.86% | 0.72 |
| PIDILITIND | ₹1,460.50 | ₹1,48,611.69Cr | 66.75 | 23.21% | 31.16% | 0.02 |
| SOLARINDS | ₹14,161.00 | ₹1,28,112.65Cr | 101.54 | 29.59% | 31.03% | 0.33 |
| SRF | ₹2,968.10 | ₹87,981.85Cr | 54.39 | 12.27% | 12.83% | 0.43 |
| FLUOROCHEM | ₹3,728.30 | ₹40,862.55Cr | 65.70 | 8.31% | 10.02% | 0.28 |
| GODREJIND | ₹1,128.40 | ₹37,194.85Cr | 36.90 | 20.50% | 10.16% | 3.73 |
| NAVINFLUOR | ₹5,905.50 | ₹30,238.26Cr | 68.09 | 11.62% | 11.76% | 0.55 |